Integrated Assessment of Percentage α2,3-Linked Sialylated Prostate-specific Antigen and the Prostate Health Index with Magnetic Resonance Imaging for Detection of Clinically Significant Prostate Cancer
We found that combining blood biomarkers called S2,3PSA% and the Prostate Health Index with MRI (magnetic resonance imaging) scan findings improved prediction of whether a patient has prostate cancer. Larger studies are needed to confirm our results.
Authors
- Hirotake Kodama (ORCID: https://orcid.org/0000-0002-5071-5149)
- Hayato Yamamoto (ORCID: https://orcid.org/0000-0002-4557-0619)
- Jotaro Mikami
- Tohru Yoneyama
- Takuma Narita (ORCID: https://orcid.org/0000-0003-2572-3590)
- Tomoko Hamaya
- Yuki Miura (ORCID: https://orcid.org/0000-0003-0963-3341)
- Chikara Ohyama
- Naoki Fujita
- Atsushi Imai
- Teppei Okamoto
- Shingo Hatakeyama
- Takuya Oishi
Institutions
- Hirosaki University (JP)
Publication Details
- Journal
- European Urology Open Science
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1016/j.euros.2025.12.012
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52